Associate Regional Business Manager (North France)

Job Location
Paris
France
Salary
Competitive
Job Description

Job Summary:

Nanostring Technologies seeks to recruit a qualified individual to fill in the newly created position in the diagnostic testing division of Associate Regional Business Manager Diagnostics France (North Region). Reporting to the Country Manager France-Benelux-UK-Switzerland, he/she will be responsible for first establishing and then growing  Nanostring’s Diagnostic business in his/her area of responsibility (Unicancer Centers,  Academic Hospitals and  Private Centers).

The successful candidate for the role will work closely with the Country Manager and European Medical Affairs Director to define Nanostring’s France commercial plan for his/her area of responsibility and its execution in the country. The successful candidate for the role will lead a part of the France commercial activities of the diagnostic version of the nCounter platform and in vitro diagnostic assays, beginning with the recently approved breast cancer assay, Prosigna. This new member of the commercial team will have direct responsibility for sales revenue.

The successful candidate for the role will work with the Country Manager to maximize sales revenues from the Unicancer Centers, academic hospitals and key Private Centers, and drive growth by articulating a thoughtful, evidence-based rationale for how practicing Oncologists and Pathologists can use Nanostring’s diagnostic tests to improve outcomes whilst also reducing costs through the accurate diagnosis and appropriate treatment of disease. The successful candidate  will consequently need to be comfortable in dialoguing with the most senior thought leaders and decision-makers in the field of Oncology, also need to analyse the market and detect the best and faster opportunities to develop the business. In addition, this position will work closely with the marketing team in order to detect, organize and execute marketing activities (congresses, tradeshows, seminars…).

Essential Functions:

  • Focus on successfully launching the Prosigna breast cancer assay in the Unicancer Centers, maximizing sales, developing the market and increasing the test demand
  • Develop a go-to-market strategy to launch Prosigna in key Private Centers and in Academic Hospitals
  • Help develop commercial and activities plan for his/her area of responsibility
  • Be responsible for own performance, checking own progress against goals  established in collaboration with line manager
  • Communicating feedback promptly with line manager and addressing issues accordingly
  • Make Prosigna known through marketing activities to the breast cancer community and attend the most relevant congresses and seminars. Marketing activities should be aligned with the Country and EU strategy and tactics, aligned with budget allocations and after medical affairs consultation ( for relevance and compliance)
  • Develop commercial activities related to Diagnostic Business for NanoString Technologies in the North part of France, in line:
    • With the strategy defined by the Country Manager and approved by Nanostring Headquarters
    • With quality policies of the company
    • With local specific regulations and both local and global regulatory matters
Requirements

Requirements:

  • Scientific background (biologist, biochemistry, pharmacy, medicine, etc…)
  • Commercial diagnostics or Pharmaceutical experience is strongly preferred
  • 5+ years of commercial leadership experience, including revenue responsibility and a proven track record of successfully launching Oncology drugs and/or diagnostics, ideally in lean and fast-paced organizations
  • Importantly,
  • Experience in Sales Development especially in growing Oncology businesses in France.
  • Experience playing a key role in launching a commercially successful drug, molecular diagnostic or have experience in the sales of a companion diagnostic to the Oncology community are of particular interest.
  • communication skills to work effectively with external constituents, such as clinicians, KOLs, as well as with internal stakeholders
  • Knowledge of diagnostic market in France
  • Specific experience in product or services in the diagnosis or treatment of breast cancer
  • Ideally, Native or resident of the country, demonstrating affinity and knowledge of the country, its culture and people
  • Strong influencing and convincing skills and experience with regards to Oncologists and Pathologists
  • Flexibility and cultural sensitivity to work in a rapidly growing yet still small company
  • Able to operate autonomously yet within a structured corporate environment
  • Driven, self-motivated, independent, dependable and passionate individual with strong leadership ability and excellent project and time management skills
  • Excellent interpersonal, communication and presentation skills
  • Good interaction with colleagues, supportive of team work.
About Our Organization

NanoString Technologies is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.

New study finds bias against female lecturers among student course evaluations, the Economist reports.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.